FDA new drug user fees proposed to offset budget cuts in President's FY 1999 request.
This article was originally published in The Tan Sheet
Executive Summary
FDA FY 1999 BUDGET WOULD INCLUDE $19 MIL. IN NEW DRUG USER FEES to offset a proposed cut of $21 mil. in the budget authority for human drugs under President Clinton's budget request for fiscal 1999 released Feb. 2. The new fees for the operating year beginning Oct. 1 would cover generic drugs and postmarketing surveillance. FDA's core review functions are protected by the Prescription Drug User Fee Act, which provides $132.3 mil. in user fees during FY 1999 and stipulates that the base appropriations may not be cut. OTC drugs approved under NDAs are subject to FDA user fees.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning